TOPIC

MEDIBANK News & Analysis

Medibank sell off was an overreaction: Morningstar
Video
Medibank sell off was an overreaction: Morningstar
Morningstar equity analyst Nathan Zaia talks about the recent change in Medibank's share price. 
Nathan Zaia | 03 November 2022
7 high quality dividend picks
Stocks
7 high quality dividend picks
Economic moats and dividend yields north of 5% in fiscal 2023.   
Nicola Chand | 08 June 2022
Opportunity for ResMed in Philips recall
Stocks
Opportunity for ResMed in Philips recall
Analysts say the incident has given the medical device company a 'rare opportunity’ to expand its market share.
Nicki Bourlioufas | 28 September 2021
Labor's election loss a welcome reprieve for health insurers
Stocks
Labor's election loss a welcome reprieve for health insurers
Share prices at NIB and Medibank bounced this week as Labor's election defeat scuttled several policies that would have likely increased member...
Glenn Freeman | 23 May 2019
Election2019: Private health scrutiny a risk for insurers, hospitals
Stocks
Election2019: Private health scrutiny a risk for insurers, hospitals
The $8.6bn promised for the healthcare means more scrutiny on insurance premiums and rebates and more pressure on insurers such as Medibank and NIB.
Morningstar Analysts | 17 May 2019
Medibank looks to buy in low growth milieu
Stocks
Medibank looks to buy in low growth milieu
Medibank Private hopes to snap up smaller rivals if they struggle to cope with premium increase limits planned by Labor if it wins this year's...
Lex Hall with AAP | 15 February 2019
Medibank profit slips 1pc to $445m
Stocks
Medibank profit slips 1pc to $445m
Medibank Private has posted a one per cent drop in full-year profit to $445.1 million as investment income declined while it improved margins in its...
AAP | 24 August 2018